Children's National Medical Center ( Site 1816)

Washington D.C., District of Columbia 20010

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028) — Completed